Skip to content

Effect of different doses of flumazenil on quality of recovery of elderly patients after endoscopic retrograde cholangiopancreatography with remimazolam general anesthesia

Effect of different doses of flumazenil on quality of recovery of elderly patients after endoscopic retrograde cholangiopancreatography with remimazolam general anesthesia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086316
Enrollment
Unknown
Registered
2024-06-28
Start date
2023-09-08
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

recovery

Interventions

0.2mg Flumazenil group:After operation, 0.2mg of flumazenil was used
0.5mg Flumazenil group:After operation, 0.5mg of flumazenil was used
1.0mg Flumazenil group:After operation, 1.0mg of flumazenil was used
0.9%NACI:Use normal saline after surgery

Sponsors

The First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Candidates for elective ERCP; 2) American Society of Anesthesiologists (ASA) Grades II to III; 3) Age 65-80 years old; 4) Body Mass index (BMI) : 18.5 ~ 23.9kg/m^2; 5) Able to complete Chinese PQRS.

Exclusion criteria

Exclusion criteria: 1) Chronic alcoholism or treatment with narcotic analgesics, sedatives, and antidepressants; 2) Have a history of psychiatric disorders (such as seizures) or cerebrovascular diseases; 3) Patients with obvious abnormal liver and kidney function: Child-Pugh grade C or blood creatinine (Scr) > 451µmol/L or blood urea nitrogen (BUN) > 17.9mmol/L; 4) Severe auditory and visual impairment, poor communication ability; 5) Patients who are allergic to medications such as flumazenil or remazolam or who refuse to participate. 6) Patients who temporarily change the mode of surgery or anesthesia; 7) Patients receiving other sedative supplements (cyclopofol); 8) The operation duration is too long or too short (> 90min or < 20min).

Design outcomes

Primary

MeasureTime frame
open eyes time;PQRS;

Secondary

MeasureTime frame
time to activity recovery;awake time;time to arrive get out PACU;complication;

Countries

China

Contacts

Public ContactZhu Yunsheng

The First Affiliated Hospital of Nanchang University

zyunsheng@126.com+86 138 7064 3657

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026